1. Home
  2. MRNA vs GLW Comparison

MRNA vs GLW Comparison

Compare MRNA & GLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • GLW
  • Stock Information
  • Founded
  • MRNA 2010
  • GLW 1851
  • Country
  • MRNA United States
  • GLW United States
  • Employees
  • MRNA N/A
  • GLW N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • GLW Telecommunications Equipment
  • Sector
  • MRNA Health Care
  • GLW Industrials
  • Exchange
  • MRNA Nasdaq
  • GLW Nasdaq
  • Market Cap
  • MRNA 34.6B
  • GLW 33.9B
  • IPO Year
  • MRNA 2018
  • GLW N/A
  • Fundamental
  • Price
  • MRNA $54.82
  • GLW $46.51
  • Analyst Decision
  • MRNA Hold
  • GLW Buy
  • Analyst Count
  • MRNA 16
  • GLW 12
  • Target Price
  • MRNA $95.93
  • GLW $48.08
  • AVG Volume (30 Days)
  • MRNA 5.0M
  • GLW 4.3M
  • Earning Date
  • MRNA 11-07-2024
  • GLW 10-29-2024
  • Dividend Yield
  • MRNA N/A
  • GLW 2.42%
  • EPS Growth
  • MRNA N/A
  • GLW N/A
  • EPS
  • MRNA N/A
  • GLW 0.51
  • Revenue
  • MRNA $5,050,000,000.00
  • GLW $12,393,000,000.00
  • Revenue This Year
  • MRNA N/A
  • GLW $14.42
  • Revenue Next Year
  • MRNA $5.29
  • GLW $6.80
  • P/E Ratio
  • MRNA N/A
  • GLW $91.09
  • Revenue Growth
  • MRNA N/A
  • GLW N/A
  • 52 Week Low
  • MRNA $54.82
  • GLW $25.26
  • 52 Week High
  • MRNA $170.47
  • GLW $47.45
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 25.28
  • GLW 62.02
  • Support Level
  • MRNA $55.70
  • GLW $45.68
  • Resistance Level
  • MRNA $59.73
  • GLW $47.23
  • Average True Range (ATR)
  • MRNA 2.17
  • GLW 0.97
  • MACD
  • MRNA 0.29
  • GLW 0.01
  • Stochastic Oscillator
  • MRNA 0.00
  • GLW 72.59

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About GLW Corning Incorporated

Corning is a leader in materials science, specializing in the production of glass, ceramics, and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.

Share on Social Networks: